The Market Is Losing Its Leaders: Defensive Rotation Deepens as Correction Risk Rises
Weekly Market Trend & Sector Analysis | November 20, 2026
Market Regime: Late-Cycle Defensive Transition | Trend Stage: Late Trend | Risk Level: High | Outlook: 1–3 Weeks
The stock market is sending an increasingly cautious message. What initially appeared to be a rotation away from technology and aggressive growth is now developing into a broader deterioration in market momentum. The S&P 500 oscillator has fallen to its weakest reading in four weeks, mega-cap technology leadership is deteriorating, and the median market capitalization of the screened universe has contracted sharply.
There are still pockets of strength, particularly consumer staples and healthcare. However, defensive leadership alone cannot compensate for the weakening participation of influential market leaders. The central question is whether the market is preparing for a deeper correction or approaching an oversold condition that could eventually produce a recovery.
1. Market Trend Analysis
The S&P 500 Is Losing Momentum
The most important development is the deterioration in the S&P 500 oscillator. Over the four weekly observations, the reading moved from -1 to -4, briefly improved to -3, and then declined sharply to -8.
This sequence suggests that the earlier stabilization failed. The market has not established a durable recovery, and the latest deterioration indicates that selling pressure or negative momentum is becoming more pronounced.
Equally important, the equal-weighted S&P 500 ETF (RSP) is also negative at -2, while small-cap IJR is at -4 and mid-cap MDY is at -7. This indicates that weakness is not confined entirely to mega-cap technology. Smaller and medium-sized companies are also struggling, with mid-caps showing particularly weak momentum.
Market Breadth and Capitalization: A Warning Signal
The median market capitalization has declined substantially over the last three weekly observations. This is an important change in the composition of the screened stock universe and suggests that smaller companies are increasingly represented in the current selection.
Nasdaq representation has also declined from 56.9% to 55.0%, while NYSE/Amex representation has moved from 43.1% to 35.0%. The latest exchange percentages do not account for the entire universe, so the remaining classification should not be interpreted as exchange migration.
These figures measure stock representation, not trading volume or institutional capital flows. Nevertheless, the declining median capitalization, negative index oscillator, and weakening mid- and small-cap momentum collectively argue against calling this a healthy broad-market expansion.
Mega-Cap Leadership: The Biggest Concern
The deterioration among the largest technology companies is perhaps the most important warning in the current analysis.
- NVIDIA: Momentum has deteriorated dramatically, with its oscillator falling from -33 to -47.
- Alphabet: Both share classes have weakened further, moving from approximately -22/-23 to -28/-29.
- Meta: Momentum has deteriorated from -14 to -22.
- Tesla: The oscillator has declined from -8 to -15.
- Amazon: Has moved from neutral territory into negative momentum.
- Apple: Remains positive, but its oscillator has weakened from +9 to +7.
- Microsoft: Remains marginally positive, but momentum has declined from +6 to +1.
Five of the seven major companies are now showing negative momentum, counting Alphabet as one company. Apple and Microsoft are still providing some support, but their positive readings are weakening.
This is not a healthy leadership structure. NVIDIA's particularly deep negative reading is concerning because semiconductor and AI-related leadership has been an important driver of market enthusiasm.
My interpretation: Mega-cap leadership is breaking down rather than confirming the broader market trend. A recovery in these companies would be necessary before considering the latest market weakness a temporary correction.
Sector Rotation: Healthcare and Consumer Staples Hold Up
Defensive sectors continue to outperform the broader market on an oscillator basis, although healthcare momentum has cooled from its recent highs.
Healthcare ETFs remain positive. XLV has an oscillator of +10, VHT is +8, and XHS is +9. Their readings have declined from the previous week's stronger levels, suggesting that healthcare leadership is still intact but losing some momentum.
Consumer staples are showing greater stability. XLP remains at +6, while VDC is at +5. These are particularly important signals because consumer staples businesses tend to have more resilient demand during periods of economic uncertainty.
Other observations include:
- SCHD (+5): Dividend-oriented exposure remains relatively resilient.
- KIE (+2): Insurance exposure remains positive, although its uptrend is weak.
- DBC (+3): Commodity momentum remains positive, but its overall sector ranking is not strong.
- XLF (-2): Financial-sector momentum has deteriorated.
- XLB (-3): Materials are showing weakness.
- IJR (-4) and MDY (-7): Smaller and medium-sized companies remain under pressure.
The important distinction is that positive oscillator readings do not necessarily mean a strong established uptrend. Consumer staples currently have the clearest sector leadership, while healthcare is experiencing a moderation in momentum.
Fundamental Quality: Where Strong GPA Stocks Are Emerging
The GPA screen continues to identify fundamentally strong companies. Insurance, capital markets, biotechnology, and healthcare businesses account for a substantial portion of the highest-quality names.
Companies such as Arthur J. Gallagher, Intercontinental Exchange, Cboe Global Markets, Eli Lilly, and several biotechnology companies demonstrate that strong fundamental quality remains available.
However, GPA and oscillator readings measure different things. Strong GPA indicates business quality, not necessarily immediate price appreciation. The combination of high GPA and improving price momentum would be a more convincing leadership signal.
The current evidence favors selective quality investing rather than indiscriminate growth exposure.
2. Economic Outlook
The market structure is increasingly consistent with a late-cycle economic environment in which investors are becoming more concerned about the sustainability of economic growth and corporate earnings. The persistent preference for healthcare and consumer staples suggests demand for earnings stability and defensive business models. Meanwhile, weakening mega-cap technology leadership and deteriorating mid- and small-cap momentum indicate that investors are becoming less willing to accept elevated growth risk without confirmation. Commodity exposure retains some positive momentum, suggesting that inflation sensitivity has not disappeared, although the current data does not establish a renewed inflation shock. Overall, market sentiment is cautious and increasingly defensive. Liquidity and risk appetite appear selective rather than broadly supportive of equities. These market indicators raise the possibility of economic deceleration, but they do not independently establish that a recession has begun.
3. Investment Ideas
I would prioritize capital preservation while maintaining selective equity exposure. Consumer staples, healthcare, quality dividend investments, and fundamentally strong insurance and healthcare businesses deserve preference. Large-cap defensive companies are currently more attractive than speculative growth stocks and smaller economically sensitive companies. I would avoid aggressively adding to semiconductor and high-beta technology exposure until mega-cap momentum stabilizes. Broad commodities remain worth monitoring, but the current signal is not strong enough to justify treating them as a leading allocation. The preferred style is quality and defensive value rather than speculative growth, with disciplined position sizing and additional cash flexibility. A recovery in the S&P 500 oscillator and improving participation from mega-cap technology should be prerequisites for a more aggressive allocation.
4. ETF Opportunities
- VDC – Vanguard Consumer Staples ETF: One of the strongest sector rankings and positive momentum.
- XLP – Consumer Staples Select Sector SPDR Fund: Consistent defensive leadership.
- XLV – Health Care Select Sector SPDR Fund: Positive momentum despite a recent slowdown.
- XHS – SPDR S&P Health Care Services ETF: Strong relative momentum within healthcare.
- VHT – Vanguard Health Care ETF: Broad healthcare exposure with a positive oscillator.
- SCHD – Schwab U.S. Dividend Equity ETF: Quality and dividend-oriented exposure.
- SPLV – Invesco S&P 500 Low Volatility ETF: Defensive portfolio exposure, although its longer-term growth signal warrants caution.
- KIE – SPDR S&P Insurance ETF: Selective insurance exposure in a late-cycle environment.
- DBC – Invesco DB Commodity Index Tracking Fund: Positive commodity momentum, but not a leading sector ranking.
- INDA – iShares MSCI India ETF: A selective international opportunity with positive momentum.
5. Top 7 ETFs to Research
- VDC – Vanguard Consumer Staples ETF: My preferred defensive candidate because consumer staples currently hold the strongest sector ranking.
- XLP – Consumer Staples Select Sector SPDR Fund: Stable positive momentum and exposure to essential-consumption businesses.
- XLV – Health Care Select Sector SPDR Fund: Healthcare remains a major source of relative strength despite its recent momentum slowdown.
- XHS – SPDR S&P Health Care Services ETF: Strong positive oscillator and exposure to healthcare services.
- VHT – Vanguard Health Care ETF: Diversified healthcare exposure with positive momentum.
- SCHD – Schwab U.S. Dividend Equity ETF: A quality and dividend-oriented candidate suited to a defensive market environment.
- SPLV – Invesco S&P 500 Low Volatility ETF: A potential defensive allocation while broader market momentum remains weak.
Portfolio note: XLV, XHS, and VHT have overlapping healthcare exposure. VDC and XLP also substantially overlap. These are ranked research candidates, not seven independent positions that should automatically be purchased together.
Market Prediction: What Comes Next?
My base case for the next 1–3 weeks is continued volatility, with a greater probability of further consolidation or downside pressure than an immediate sustainable recovery.
The deterioration in the S&P 500 oscillator, weakening mega-cap leadership, and declining median market capitalization create an unfavorable combination. Healthcare and consumer staples provide some stability, but they are not yet sufficient to confirm a broader market recovery.
There are two important developments to watch. First, NVIDIA, Alphabet, Meta, and Amazon must begin improving their oscillator readings. Second, the S&P 500 oscillator must recover from its deeply negative territory, accompanied by improving equal-weighted and small-cap participation.
If these developments occur together, the market could begin establishing a new upward leg. If they do not, defensive rotation could continue and the risk of a deeper correction will remain elevated.
Final Assessment
- Market Regime: Late-Cycle Defensive Transition
- Trend Stage: Late Trend / Corrective Phase
- Risk Level: High
- Breadth: Weakening and increasingly selective
- Sector Leadership: Consumer Staples and Healthcare
- Preferred Style: Quality, Defensive Value and Dividends
- Preferred Positioning: Capital Preservation with Selective Equity Exposure
- Near-Term Outlook: Cautious; further downside remains a meaningful risk
My additional observations
There are three developments I would pay particularly close attention to in next week's data.
NVIDIA and the semiconductor complex: NVIDIA's oscillator of -47 is a significant deterioration. I would not consider a technology recovery confirmed until semiconductor leadership starts improving.
Consumer staples versus healthcare: Consumer staples are becoming more consistent leaders. Healthcare is still strong, but its oscillator is declining. This could indicate a second stage of defensive rotation.
The median market-cap decline: This deserves investigation in your next dataset. If the decline persists while SPY remains negative, it would reinforce the risk-off interpretation.
One important qualification: The latest data is more bearish than November 13, but it does not yet establish a capitulation bottom. A deeply negative oscillator can eventually produce a powerful reversal, but I would want to see improving momentum before treating it as a buying signal.
This analysis is based on weekly market screening data and represents a conditional assessment, not a guarantee of future market performance.
Stats for 2026-11-20 (3rd week of the Month)
List creation date: 2026-11-20
Median MarketCap: 3895
55.0% stocks on Nasdaq; 35.0% stocks on NYSE/Amex
| Sector | |
|---|---|
| Unclassified | 45% |
| Financials | 21% |
| Health Care | 18% |
| Information Technology | 6% |
| Consumer Discretionary | 6% |
| Industrials | 3% |
| Industry | |
|---|---|
| Unclassified | 45% |
| Biotechnology | 15% |
| Insurance | 9% |
| Capital Markets | 6% |
| Software | 3% |
| Communications Equipm | 3% |
| Professional Services | 3% |
| Household Durables | 3% |
| Leisure Products | 3% |
| Pharmaceuticals | 3% |
| Banks | 3% |
| Financial Services | 3% |
| Country | |
|---|---|
| United States | 88% |
| India | 3% |
| Netherlands | 3% |
| Switzerland | 3% |
| United Kingdom | 3% |
| GPA | Sym | (0gpaamp5) Industry | Sector | MktCap | Country | Name |
|---|---|---|---|---|---|---|
| 3.92 | AJG | Insurance | Financials | 71186 | US | Arthur J. Gallagher & |
| 3.92 | SKWD | Insurance | Financials | 2822 | US | Skyward Specialty Insurance Gr |
| 3.80 | AFG | Insurance | Financials | 12982 | US | American Financial Group, |
| 3.92 | ICE | Capital Markets | Financials | 95498 | US | Intercontinental Exchange, |
| 3.92 | CBOE | Capital Markets | Financials | 37318 | US | Cboe Global Markets, |
| 3.96 | IBN | Banks | Financials | 123832 | India | ICICI Bank Limited |
| 3.80 | FLYW | Financial Services | Financials | 2622 | US | Flywire |
| 3.96 | ONC | Biotechnology | Health Care | 45656 | Switzerland | BeOne Medicines AG |
| 3.96 | KNSA | Biotechnology | Health Care | 7349 | United Kingdom | Kiniksa Pharmaceuticals Intern |
| 3.96 | VCEL | Biotechnology | Health Care | 2973 | US | Vericel |
| 3.92 | ALEC | Biotechnology | Health Care | 342 | US | Alector, |
| 3.88 | ARGX | Biotechnology | Health Care | 58855 | Netherlands | argenx SE |
| 3.96 | ETON | Pharmaceuticals | Health Care | 1770 | US | Eton Pharmaceuticals, |
| 3.80 | CRCT | Household Durables | Consumer Discretionary | 1729 | US | Cricut, |
| 3.88 | RGR | Leisure Products | Consumer Discretionary | 827 | US | Sturm, Ruger & Company, |
| 3.88 | AVPT | Software | Information Technology | 3559 | US | AvePoint, |
| 3.80 | MSI | Communications Equipm | Information Technology | 86291 | US | Motorola Solutions, |
| 3.92 | EXPO | Professional Services | Industrials | 4232 | US | Exponent, |
| 1.76 | SPY | Unclassified | Unclassified | -1 | US | SPY |
| na | QQQ | Unclassified | Unclassified | -1 | US | QQQ |
0GPA38TB (* means Wkly fast and slow Fract individually, stronger then SPY).
| % Alloc | Sym | Name_currentList | Sym | Action | Sector | sharesHld | DlrHld | allocHld | Price |
|---|---|---|---|---|---|---|---|---|---|
| 10% | LLY | LILLY ELI & CO | LLY | Health Care | 1 | $1,347.1 | 12.2% | $1347.11 | |
| 24% | QQQ | Powershrs Qqq Trust Sr 1 | QQQ | n.a. | 4 | $2,433.8 | 22.1% | $608.45 | |
| 25% | SPY | SPDR S&P 500 | SPY | n.a. | 4 | $2,759.2 | 25.0% | $689.81 | |
| 11% | *WELL | Welltower Inc | WELL | Real Estate | 5 | $1,201.7 | 10.9% | $240.34 | |
| 9% | TXN | TEXAS INSTRUMENTS | removed | Information Technology | 4 | $1,055.0 | 9.6% | $263.75 | |
| 10% | V | VISA INC CL A | removed | Financials | 3 | $1,205.6 | 10.9% | $401.87 | |
| 10% | ABNB | Airbnb Inc | removed | Consumer Discretionary | 6 | $1,022.2 | 9.3% | $170.36 |
| Style</> | % Alloc | Shares | Symbol | Name | Date | |
|---|---|---|---|---|---|---|
| growth | 5.25 | 2 | VDC | Consumer Staples | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 5 | XLP | Consumer Staples Select | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 2 | XLV | Health Care Select | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 1 | VHT | Health | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 8 | KIE | Insurance | Late Cycle and Inflation | 2026-11-20 |
| growth | 5.25 | 6 | SPLV | Invesco S&P 500 Low Volatility* | 2026-11-20 | |
| cyclical | 5.25 | 9 | INDA | India* | 2026-11-20 | |
| cyclical | 5.25 | 6 | XRT | Retail | Mid to Early Cycle | 2026-11-20 |
| cyclical | 5.25 | 8 | NOBL | ProShares S&P 500 Dividend Aristocrats* | 2026-11-20 | |
| Style</> | % Alloc | Shares | Symbol | Name | Date | |
|---|---|---|---|---|---|---|
| growth | 5.25 | 2 | VDC | Consumer Staples | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 5 | XLP | Consumer Staples Select | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 2 | XLV | Health Care Select | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 1 | VHT | Health | Late Cycle to Recession | 2026-11-20 |
| growth | 5.25 | 6 | SPLV | Invesco S&P 500 Low Volatility* | 2026-11-20 | |
| growth | 5.25 | 8 | KIE | Insurance | Late Cycle and Inflation | 2026-11-20 |
| growth | 5.25 | 15 | SCHD | US Dividend Equity | 2026-11-20 | |
| cyclical | 5.25 | 6 | XRT | Retail | Mid to Early Cycle | 2026-11-20 |
| cyclical | 5.25 | 8 | NOBL | ProShares S&P 500 Dividend Aristocrats* | 2026-11-20 | |
| cyclical | 5.25 | 9 | INDA | India* | 2026-11-20 | |
| # | %Alloc | Share | Sym | Name | Industry | Date | GPA | Ver |
|---|
| Symbol | Bound | Osc | Max Fract | Percent tile | Draw Down | Draw Down 7yr | cagr 7Yr | Name | cagr By dd | score |
|---|---|---|---|---|---|---|---|---|---|---|
| DGX | 1.15 | 14 | 1.0 | 98 | -25 | -27 | 13.74 | Quest Diagnostics Incorporated | 50 | 16.1 |
| MSI | 1.24 | 9 | 1.1 | 42 | -21 | -25 | 17.69 | Motorola Solutions Inc. | 70 | 11.2 |
| LLY* | 0.76 | 10 | 1.2 | 78 | -35 | -21 | 42.19 | Eli Lilly and Company | 200 | 7.6 |
| CAH | 0.89 | 8 | 1.0 | 97 | -48 | -21 | 25.57 | Cardinal Health Inc. | 121 | 7.1 |
| AAPL* | 0.89 | 7 | 1.1 | 58 | -36 | -23 | 26.58 | Apple Inc. | 115 | 6.2 |
| AJG | 0.80 | 6 | 1.2 | 17 | -28 | -36 | 16.99 | Arthur J. Gallagher & Co. | 47 | 4.8 |
| COST | 1.15 | 4 | 1.1 | 34 | -26 | -20 | 20.40 | Costco Wholesale Corporation | 102 | 4.6 |
| CTAS | 1.15 | 4 | 1.1 | 24 | -25 | -23 | 19.06 | Cintas Corporation | 82 | 4.6 |
| EBAY | 0.88 | 5 | 1.1 | 99 | -60 | -49 | 18.68 | eBay Inc. | 38 | 4.4 |
| RSG | 1.11 | 4 | 1.1 | 42 | -26 | -19 | 15.91 | Republic Services Inc. | 83 | 4.4 |
| HLT | 1.12 | 3 | 1.0 | 60 | -31 | -31 | 20.03 | Hilton Worldwide Holdings Inc. | 64 | 3.4 |
| FAST | 0.73 | 2 | 1.1 | 71 | -33 | -23 | 16.26 | Fastenal Company | 70 | 1.5 |
| WRB | 0.74 | 2 | 1.2 | 51 | -23 | -25 | 14.16 | W. R. Berkley Corporation | 56 | 1.5 |
| WMT* | 1.14 | 1 | 1.0 | 89 | -24 | -19 | 18.19 | Walmart Inc. | 95 | 1.1 |
| MSFT* | 0.76 | 1 | 1.1 | 34 | -30 | -29 | 18.28 | Microsoft Corporation | 63 | 0.8 |
| SPY | 1.00 | -8 | 1.0 | 89 | -33 | -19 | 12.07 | SNP500 | 63 | -8.0 |
| MCK | 0.76 | 12 | 0.8 | 68 | -45 | -20 | 32.31 | McKesson Corporation | 161 | 9.1 |
| V* | 0.98 | 8 | 1.0 | 38 | -27 | -21 | 12.01 | Visa Inc. | 57 | 7.8 |
| GWW | 0.90 | 4 | 0.9 | 66 | -28 | -21 | 23.35 | W.W. Grainger Inc. | 111 | 3.6 |
| PANW | 0.25 | 2 | 0.8 | 92 | -36 | -27 | 35.32 | Palo Alto Networks Inc. | 130 | 0.5 |
| LIN | 1.53 | -1 | 0.8 | 4 | -19 | -18 | 13.58 | Linde plc | 75 | -1.5 |
| FTNT | 0.19 | -16 | 0.9 | 65 | -36 | -33 | 29.41 | Fortinet Inc. | 89 | -3.0 |
| AMD* | 0.23 | -16 | 0.9 | 94 | -77 | -55 | 39.65 | Advanced Micro Devices Inc. | 72 | -3.7 |
| AMZN* | 0.74 | -5 | 0.7 | 23 | -39 | -47 | 16.01 | Amazon.com Inc. | 34 | -3.7 |
| ANET | 0.29 | -15 | 0.9 | 70 | -37 | -30 | 45.52 | Arista Networks Inc. | 151 | -4.4 |
| ORLY | 0.97 | -7 | 0.9 | 16 | -21 | -19 | 17.91 | O'Reilly Automotive Inc. | 94 | -6.8 |
| TSLA* | 0.46 | -15 | 0.5 | 36 | -53 | -58 | 46.85 | Tesla Inc. | 80 | -6.9 |
| RTX | 0.70 | -11 | 1.0 | 39 | -21 | -22 | 15.88 | RTX Corporation | 72 | -7.7 |
| PWR | 0.34 | -24 | 1.1 | 92 | -46 | -23 | 44.62 | Quanta Services Inc. | 194 | -8.2 |
| JPM* | 0.88 | -11 | 1.0 | 87 | -34 | -34 | 13.29 | JPMorgan Chase & Co. | 39 | -9.7 |
| META* | 0.46 | -22 | 0.8 | 11 | -30 | -30 | 95.79 | Meta Platforms Inc. | 319 | -10.1 |
| APH | 0.47 | -22 | 1.1 | 93 | -33 | -23 | 27.43 | Amphenol Corporation | 119 | -10.3 |
| MU* | 0.19 | -56 | 0.8 | 96 | -60 | -44 | 44.33 | Micron Technology Inc. | 100 | -10.6 |
| GEV | 0.25 | -43 | 1.1 | 50 | -28 | -28 | 84.34 | GE Vernova Inc. | 301 | -10.8 |
| HWM | 0.34 | -32 | 1.2 | 65 | -18 | -18 | 51.60 | Howmet Aerospace Inc. | 286 | -10.9 |
| KLAC | 0.26 | -42 | 1.2 | 96 | -40 | -34 | 32.85 | KLA Corporation | 96 | -10.9 |
| AVGO* | 0.38 | -32 | 1.2 | 68 | -25 | -29 | 38.48 | Broadcom Inc. | 132 | -12.2 |
| NVDA* | 0.27 | -47 | 1.0 | 56 | -58 | -52 | 57.25 | NVIDIA Corporation | 110 | -12.7 |
| CASY | 0.85 | -16 | 1.1 | 95 | -22 | -20 | 21.95 | Casey's General Stores Inc. | 109 | -13.6 |
| EME | 0.44 | -34 | 1.1 | 84 | -36 | -30 | 31.49 | EMCOR Group Inc. | 104 | -15.0 |
| GOOGL* | 0.55 | -29 | 1.0 | 86 | -30 | -34 | 22.23 | Alphabet Inc. | 65 | -16.0 |
| GOOG* | 0.58 | -28 | 1.0 | 89 | -34 | -34 | 22.13 | Alphabet Inc. | 65 | -16.2 |